Cannabis Business Loans: Navigating Banking Restrictions and Business Realities

We’d love nothing more than to tell our prospective borrowers in the cannabis industry that mainstream bank loans are right around the corner. We would close more loans and be more profitable if banks were equipped to execute loans reliably in the industry based on cannabis valuations, and reasonable time frames. The day that happens, we’ll partner with more banks. Meanwhile, as much as we would love to quote single digit costs of debt capital in the industry, it almost never really exists. HEF Finance remains the firm that delivers the real news based on having underwritten hundreds of millions of dollars in loans over the last 7 years. More often than not, the real news is not exactly what borrowers want to hear. That said, the news is that cannabis loans for businesses are available, and can be executed in reasonable time frames. However, the cost is still at a premium.

The cannabis industry is one of the fastest-growing industries in the United States, with sales expected to reach $44.7 billion by 2026. However, cannabis businesses still face significant challenges in accessing traditional banking services, making it difficult to obtain loans. Despite efforts to reform regulations and improve access to capital, cannabis loans remain difficult to execute. In this article, we will explore the traditional difficulties associated with cannabis loans, the compounding effects of banking restrictions, and why even the Safe Banking Act and rescheduling of cannabis may not provide an immediate solution.

The Traditional Difficulty of Cannabis Loans

Cannabis businesses have long struggled to secure financing due to the federal prohibition of marijuana. This legal limbo makes banks and traditional financial institutions wary of getting involved with an industry that is subject to conflicting state and federal laws. As a result, cannabis entrepreneurs have been forced to rely on alternative sources of funding, such as private investors and venture capital.

Banking Restrictions and Their Compounding Effects

The banking restrictions imposed on the cannabis industry have far-reaching consequences. They create a cash-heavy environment, which poses security risks and makes it challenging to manage finances effectively. Additionally, without access to traditional banking services, cannabis businesses face difficulties in obtaining loans at competitive interest rates. This, in turn, affects their ability to expand operations, invest in research and development, and remain competitive in the market.

The Safe Banking Act and Rescheduling Efforts

While the introduction of the Safe Banking Act and discussions about rescheduling cannabis from a Schedule I to a Schedule III drug have generated hope, they are unlikely to bring immediate relief to the industry. The bureaucratic processes involved in legislative changes and the lingering stigma surrounding cannabis mean that it may take years before these measures have a significant impact. In the short term, cannabis businesses will still need to navigate the challenging lending landscape.

Comparing Cannabis Loans to "Sin" Industries

To put the challenges of cannabis loans into context, it's worth noting that even long-established "sin" industries like tobacco, firearms, and liquor have faced lending restrictions for over a century. These industries, despite being legal, still encounter hurdles when seeking financing due to various factors, including regulatory scrutiny and social concerns. The cannabis industry's struggle is, in many ways, an extension of this historical trend.

The Role of Experienced Firms

In the face of these challenges, few firms have extensive experience in executing cannabis business loans reliably. This lack of expertise can further complicate the loan application process for cannabis entrepreneurs. However, there are private money pools that have proven their ability to execute loans predictably, providing a lifeline for businesses in need of capital.

HEF Finance: A Reliable Partner

HEF Finance is one such firm that has been executing cannabis loans for seven years with a track record of reliability. While HEF Finance acknowledges the desire to partner with banks offering cheap and reliable capital, they emphasize the historically unreliable execution risk associated with traditional financial institutions.

Industry Growth and Stock Market Woes

Despite the hurdles, the cannabis industry continues to experience remarkable growth. Sales have surged in 2023 and are projected to continue growing in the years to come. However, certain cannabis business stocks have taken a beating due to factors such as the burdensome 280E tax laws, which disallow ordinary business deductions for marijuana companies. Additionally, other issues, such as market saturation and increased competition, have contributed to stock price fluctuations.


The challenges of obtaining cannabis loans persist, despite the industry's rapid growth and changing legal landscape. While legislative efforts like the Safe Banking Act and rescheduling of cannabis hold promise for the future, they are unlikely to provide immediate solutions. As demonstrated by the experiences of "sin" industries, lending restrictions can persist for decades, if not longer.

For now, experienced firms like HEF Finance and private money pools remain the most reliable sources of capital for cannabis businesses. As the industry continues to evolve, it is crucial for entrepreneurs and investors to stay vigilant, adapt to changing regulations, and explore alternative financing options to navigate the unique challenges of the cannabis market.

Back to Blog list
hef finance logo

Get an expert cannabis finance consultation with an

HEF Finance expert Today.

Book your Consultation